SCHEMBL7708877

SCHEMBL7708877

O=C(O)c1ccc(CC(Cn2ccnc2)c2nccs2)cc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
HIF1A Q16665 1/20 0.41
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
TBXAS1 P24557 3/20 0.40
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
PGGT1B P53609 1/20 0.39
CYP19A1 P11511 2/20 0.39
PDE4A P27815 1/20 0.38
CTSA P10619 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP17A1 P05093 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7240383 0.90 FNTA (0.41) NPC1RAB9ASMN1; SMN2LMNAHTT
SCHEMBL7703414 0.84 FNTA (0.45) NPC1RAB9ASMN1; SMN2LMNAHTT
SCHEMBL8207459 0.77 CTSA (0.39) CTSA
SCHEMBL7564332 0.77 IDO1 (0.45) SMN1; SMN2LMNAHTTHIF1ATBXAS1
SCHEMBL7564344 0.69 CYP19A1 (0.40) SMN1; SMN2LMNATBXAS1FNTAFNTB
SCHEMBL7563092 0.65 PTGS2 (0.52) SMN1; SMN2LMNAHTTHIF1ATBXAS1
SCHEMBL7561297 0.65 TBXAS1 (0.38) SMN1; SMN2TBXAS1CYP19A1CYP3A4CYP2C9
SCHEMBL6306399 0.65 CYP19A1 (0.50) CYP19A1
SCHEMBL6979561 0.64 CYP19A1 (0.59) CYP11B1CYP11B2TBXAS1CYP19A1CYP3A4
SCHEMBL7247326 0.63 CYP11B1 (0.39) LMNACYP11B1CYP11B2FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414145-B1 TREATING CANCER AND NEUROFIBROMATOSIS ZENECA LIMITED (GB) 2002-07-02 US disclosed